Insulin Degludec (2.56mg) + Insulin Aspart (1.05mg) is manufactured by Novo Nordisk India Pvt Ltd
Insulin degludec and insulin aspart. Insulin degludec has a prolonged duration of action while insulin aspart has a fast onset of action. Together, they ensure rapid and consistent sugar control by facilitating reuptake of sugar in muscle and fat cells, and suppressing the production of sugar in the liver.
This is available in a 1 Cartridge of 3 Ml format with an MRP of ₹1238.6.
If you experience any persistent or severe side effects, consult your doctor immediately.
It is unsafe to consume alcohol with Ryzodeg 100IU/ml Penfill.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Ryzodeg 100IU/ml Penfill is safe to use in patients with kidney disease. No dose adjustment of Ryzodeg 100IU/ml Penfill is recommended. However, frequent and regular monitoring of blood glucose levels is advised.
Ryzodeg 100IU/ml Penfill is safe to use in patients with liver disease. No dose adjustment of Ryzodeg 100IU/ml Penfill is recommended. However, frequent and regular monitoring of blood glucose levels is advised.
Ryzodeg 100IU/ml Penfill may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Ryzodeg 100IU/ml Penfill during breastfeeding is not available. Please consult your doctor.


100% Genuine
Medicines
No
Return
Online
Payment Only
Novo Nordisk India Pvt Ltd
1 Cartridge of 3 Ml
100% Genuine
Medicines
No
Return
Online
Payment Only
Novo Nordisk India Pvt Ltd
1 Cartridge of 3 Ml